Availability will vary by state, and a pharmacy professor says cost barriers can keep families from getting vaccinated.
Feature|Articles|August 10, 2026
The Effects of COVID-19 Influencing the Development of Vaccines
Author(s)Ashley Gallagher, MA
A decades-long research effort in mRNA-produced licensed vaccines targets influenza, respiratory syncytial virus, cytomegalovirus, HIV, and cancer.
Advertisement
Advertisement
Messenger RNA (mRNA) vaccine technology, first proposed in the early 1970s and confirmed in the laboratory only in the late 1990s, remained a largely experimental concept for 2 more decades.1
Related to this article
A structured recommendation workflow at a community pharmacy was associated with more multivaccine patients than routine practice.
Researchers compared vaccine coadministration with single-dose, sequential vaccination for the RSVPreF3 OA vaccine formulation in adults.
Darren Mensch, PharmD, BCPS, BCACP, provides evidence-based nuance regarding the emergence of mRNA vaccine technology and health care’s understanding of it.
Pharmacist pain clinics typically focus on comprehensive medication management involving the entire patient scenario.
A case shows a suspected recurrence of pneumococcal disease that ended with removal of one cochlear implant and replacement of the other.
Detailed phase 3 data show retatrutide lowered body weight and A1C over 80 weeks for patients with diabetes and obesity.
In celebration of the organization’s recent convention, NCPA released its annual digest report for members, providing a detailed overview of independent community pharmacy.
Advertisement
Advertisement